
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Toxins (2023) Vol. 15, Iss. 5, pp. 342-342
Open Access | Times Cited: 17
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Toxins (2023) Vol. 15, Iss. 5, pp. 342-342
Open Access | Times Cited: 17
Showing 17 citing articles:
The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
Salvatore Facciorusso, Stefania Spina, Alessandro Picelli, et al.
Toxins (2024) Vol. 16, Iss. 4, pp. 184-184
Open Access | Times Cited: 9
Salvatore Facciorusso, Stefania Spina, Alessandro Picelli, et al.
Toxins (2024) Vol. 16, Iss. 4, pp. 184-184
Open Access | Times Cited: 9
Update on Non-Interchangeability of Botulinum Neurotoxin Products
Mitchell F. Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 266-266
Open Access | Times Cited: 7
Mitchell F. Brin, Mariana Nelson, Nazanin Ashourian, et al.
Toxins (2024) Vol. 16, Iss. 6, pp. 266-266
Open Access | Times Cited: 7
Immunogenicity of Botulinum Toxin A: Insights
Eqram Rahman, Jean Carruthers
Dermatologic Surgery (2024) Vol. 50, Iss. 9S, pp. S117-S126
Closed Access | Times Cited: 7
Eqram Rahman, Jean Carruthers
Dermatologic Surgery (2024) Vol. 50, Iss. 9S, pp. S117-S126
Closed Access | Times Cited: 7
Versatility of OnabotulinumtoxinA in Aesthetic Medicine
Mitchell F. Brin, John Maltman, Mary Ann Chapman, et al.
Dermatologic Surgery (2024) Vol. 50, Iss. 9S, pp. S12-S17
Closed Access | Times Cited: 2
Mitchell F. Brin, John Maltman, Mary Ann Chapman, et al.
Dermatologic Surgery (2024) Vol. 50, Iss. 9S, pp. S12-S17
Closed Access | Times Cited: 2
Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report
Michael U. Martin, Clifton Ming Tay, Tuck Wah Siew
Toxins (2024) Vol. 16, Iss. 10, pp. 422-422
Open Access | Times Cited: 2
Michael U. Martin, Clifton Ming Tay, Tuck Wah Siew
Toxins (2024) Vol. 16, Iss. 10, pp. 422-422
Open Access | Times Cited: 2
The Patient Journey in Facial Aesthetics: Findings from a European Consensus Meeting on Improving the Quality of Life for Patients Receiving Botulinum Toxin Injections
Wolfgang G. Philipp‐Dormston, Koenraad De Boulle, Yoav Gronovich, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 329-337
Open Access | Times Cited: 1
Wolfgang G. Philipp‐Dormston, Koenraad De Boulle, Yoav Gronovich, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 329-337
Open Access | Times Cited: 1
Immunogenicity of Botulinum Toxin Type A in Different Clinical and Cosmetic Treatment, a Literature Review
Kar Wai Alvin Lee, Lisa Kwin Wah Chan, Angela Wai Kay Lee, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access | Times Cited: 1
Kar Wai Alvin Lee, Lisa Kwin Wah Chan, Angela Wai Kay Lee, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access | Times Cited: 1
Zinc in Dermatology: Exploring Its Emerging Role in Enhancing Botulinum Toxin Formulations and Clinical Efficacy
Lacey Foster, Jose Foppiani, Helen Xun, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12088-12098
Open Access | Times Cited: 1
Lacey Foster, Jose Foppiani, Helen Xun, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12088-12098
Open Access | Times Cited: 1
The wear-off phenomenon of repeated botulinum toxin injection for chronic migraine treatment: A retrospective study
E. Rusen, Gaye Hafez, Yeşim Tunç
Turkish Journal Of Neurology (2024) Vol. 30, Iss. 1, pp. 47-55
Open Access
E. Rusen, Gaye Hafez, Yeşim Tunç
Turkish Journal Of Neurology (2024) Vol. 30, Iss. 1, pp. 47-55
Open Access
Use and Outcomes of Botulinum Toxin A for Both Neurogenic and Non-neurogenic Voiding Dysfunction in the Pediatric Patient
Israel Franco
Current Bladder Dysfunction Reports (2024) Vol. 19, Iss. 1, pp. 70-75
Closed Access
Israel Franco
Current Bladder Dysfunction Reports (2024) Vol. 19, Iss. 1, pp. 70-75
Closed Access
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?
Özgür Karcıoğlu, Canan Akman, Ilknur Atnis
Current Pharmaceutical Design (2024) Vol. 30, Iss. 8, pp. 578-588
Closed Access
Özgür Karcıoğlu, Canan Akman, Ilknur Atnis
Current Pharmaceutical Design (2024) Vol. 30, Iss. 8, pp. 578-588
Closed Access
Botulinum Toxin Therapy for Complication of Stroke
Bahman Jabbari
Springer eBooks (2024), pp. 87-100
Closed Access
Bahman Jabbari
Springer eBooks (2024), pp. 87-100
Closed Access
Treatment of Involuntary Movements (Dystonia, Tremor, Tic)
Bahman Jabbari
Springer eBooks (2024), pp. 119-143
Closed Access
Bahman Jabbari
Springer eBooks (2024), pp. 119-143
Closed Access
Current use of neurotoxins for alleviating symptoms of cervical dystonia
Stephen Aradi, Robert A. Hauser
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access
Stephen Aradi, Robert A. Hauser
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication
Grace Forde, Benjamin M. Brucker, Kimberly Becker Ifantides, et al.
Toxins (2024) Vol. 16, Iss. 10, pp. 420-420
Open Access
Grace Forde, Benjamin M. Brucker, Kimberly Becker Ifantides, et al.
Toxins (2024) Vol. 16, Iss. 10, pp. 420-420
Open Access
Toxina botulínica. ¿Por qué dura menos? Una revisión desde nuestra experiencia
Fernando García Monforte, Justo Miguel Alcolea López
Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME) (2023), Iss. 76
Open Access | Times Cited: 1
Fernando García Monforte, Justo Miguel Alcolea López
Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME) (2023), Iss. 76
Open Access | Times Cited: 1